John D. Gearhart's response to President Bushs stem cell decision

First, I want to say that I recognize and respect President Bushs decision and the attention he paid to the complexity and difficulty of the issues. Im pleased that he is enabling some of this work to go forward with federal funding, which is vital to efforts to accelerate progress in bringing stem cell research to the clinic.

The President's policy has some limitations, but it is a good place to start to expand the base of scientists doing this research. In the next few weeks, as details of the policy become clear, my colleagues and I will have a better sense of these limitations and what they will mean. Right now, for example, I'm uncertain about the location and origin of the 60 cell lines he referred to in his statement or how it will be determined whether a particular cell line existed as of last nights policy declaration. There are also questions, of course, about how the research proposals and projects themselves would be overseen, whether the current NIH guidelines would be reinstated or whether the advisory committee he referred to would create a new set of guidelines.

President Bush's decision will not change the way stem cell research is done tomorrow or next week, since it will take time to make the funds available and iron out the details. But even with the limitations he's put forth, it will likely affect stem cell research positively once the systems are in place for evaluating and awarding grants and overseeing the work.

Federal funding is vital to efforts to bring the potential applications of stem cells for treating human disease to reality. Federal funding will help bring more investigators into the field to help speed up the process and will eventually add important peer review and oversight, hallmarks of good scientific research.

Through the Institute for Cell Engineering, Johns Hopkins is committed to pursuing stem cell research with the eventual goal of helping people with currently incurable diseases o

Contact: Joanna Downer
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Columbia research to examine gene influence on severity of peridontal disease, therapy response
2. Protective gene may enhance vaccine responses
3. Activated signaling pathway may predict lung cancer patients response to gefitinib
4. Duke study disputes idea that trees can relocate quickly in response to climate change
5. Researchers develop better understanding of immune response to viral infection
6. Molecular motor shuttles key protein in response to light
7. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
8. Genetic basis for individual variations in the response to stress
9. Drunken worms reveal a genetic basis of alcohol response
10. Researchers identify genetic markers to predict response to chemotherapy for colorectal cancer
11. With fat, women have a more visceral response

Post Your Comments:

(Date:8/26/2020)... and SHANGHAI (PRWEB) , ... August 24, 2020 ... ... novel approaches for the treatment of chronic inflammatory and fibrotic diseases, today announced ... and Vice President of Drug Discovery. , Dr. Canan previously served as Executive ...
(Date:8/26/2020)... ... August 25, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... PEGS Boston Virtual Conference & Expo, taking place between Aug. 31 – September ...
(Date:8/23/2020)... ... August 21, 2020 , ... ... has been published and is now available on the company’s global website. Crystallography ... X-ray analysis community, presenting current news and crystallographic research. , The latest ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products ... three different materials for use with CRM, neurostimulation, vascular, and related devices. , ... meet specific design requirements, performance, and cost criteria; especially where solid wire is ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... 200 of the top radiation centers in 16 countries, has reached its 20th ... SDX® is now in routine use at top universities including University of Pennsylvania, ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, the ... is only the beginning of a successful study, while protecting and accessing the catheter ... Global Head of Surgery from Envigo in a live webinar ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
Breaking Biology Technology:
Cached News: